Boston Scientific

Traded on the St. Petersburg Stock Exchange
Boston Scientific is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Boston Scientific stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Boston Scientific balance sheet

Report period2018 2019 2020 2021 2022Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Boston Scientific cash flows

Report period2018 2019 2020 2021 2022Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Boston Scientific multipliers

Report period2018 2019 2020 2021 2022Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Boston Scientific profitability

Report period2018 2019 2020 2021 2022Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Boston Scientific assets
Boston Scientific cash flows

Boston Scientific shares

TickerNameTypeNominal valueISINPrice
BSX:USBoston Scientific CorporationCommon share-US1011371077$67.62
Boston Scientific news
27.04.2022
Boston Scientific's GAAP net income for 3 months of 2022 was $110 million, down 3.1 times from $341 million in the previous year. Revenues rose 10% to $3.026 billion from $2.752 billion a year earlier.
Source: news.bostonscientific.com
Pictogram next
12.04.2022
FDA has approved the use of Boston Scientific's STIMVIEW XT software. The technology allows you to build 3D models to monitor the brain when treating Parkinson's disease or essential tremor with electrodes. With STIMVIEW XT, electrode placement time is reduced by 56% to about 20 minutes.
Source: news.bostonscientific.com
Pictogram next
15.02.2022
Boston Scientific Corporation has completed its $1.75 billion acquisition of heart disease catheter developer Baylis Medical Company. The deal has allowed Boston Scientific to become one of the largest companies to provide a full suite of tools for left atrial auricle closure and atrial fibrillation ablation.
Source: news.bostonscientific.com
Pictogram next
02.02.2022
Boston Scientific's GAAP net income for 2021 was $1.041 billion, compared to a loss of $0.082 billion in the previous year. Revenue increased 26.8% to $8.177 billion from $6.448 billion a year earlier.
Source: news.bostonscientific.com
Pictogram next
All Boston Scientific news
General information
Company nameBoston Scientific
Tags#medtech, #s&p500 index
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 508-683-4000
Mailing address300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234
Websitewww.bostonscientific.com
Information disclosurewww.sec.gov